Related Experiment Videos
[Primary biliary cirrhosis associated with pericardial effusion]
B Agraou1, T Le Tourneau, H Agraou
1Service de Cardiologie et de Soins Intensifs, Centre Hospitalier, Douai.
Annales De Cardiologie Et D'Angeiologie
|November 11, 1998
Summary
This case study shows that colchicine and ursodesoxycholic acid effectively treated pericardial effusion in a patient with primary biliary cirrhosis and antiphospholipid antibodies. The effusion resolved and did not return after treatment.
Area of Science:
- Hepatology
- Cardiology
- Rheumatology
Background:
- Primary biliary cirrhosis (PBC) is a chronic liver disease.
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with blood clots and pregnancy complications.
- Pericardial effusion is the buildup of excess fluid around the heart.
Observation:
- A patient with primary biliary cirrhosis and antiphospholipid antibodies presented with a moderate pericardial effusion.
- The patient's condition was managed with a combination of Colchicine and ursodesoxycholic acid.
Findings:
- The pericardial effusion resolved completely following treatment with Colchicine and ursodesoxycholic acid.
- No recurrence of the pericardial effusion was observed after the treatment regimen.
Implications:
- This case suggests a potential therapeutic role for Colchicine and ursodesoxycholic acid in managing pericardial effusion in patients with PBC and APS.
- Further research is warranted to explore this treatment combination in similar clinical scenarios.